Bill® Melatonin 3 mg Tablets
Natural health product licensed in Canada
- Licence holder
- Bill Beauty & Health Products Ltd.
- NPN or DIN-HM
- 80002396
- Status
- Active licence
- Licence date
- 28 November 2006
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-[2-(5-méthoxyindol-3-yl)éthyl] acétamide | 3 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose - microcrystalline, Carbonate de calcium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | Not specified |
Uses authorised in Canada
Melatonin helps increase the total sleep time (aspect of sleep quality) in people sufferring from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps relieve the daytime fatigue associated with jet lag. Helps to reduce the time it takes to fall asleep (Sleep onset latency aspect of sleep quality) in people with delayed sleep phase syndrome. Helps re-set the body's sleep-wake cycle.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are taking immunosuppressive drugs.
- Effets indésirables connus
No known adverse effects.
- Précautions et mises en garde
Do not drive or use heavy machinery for 6 hours after taking melatonin. Do not use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have a hormonal disorder, diabetes, liver or kidney disease, serebral palsey, seizure disorders, migraine, depression and/or hypertension or if you are taking blood pressure or sedative/hypnotic medications. If symptoms persist continuously for more than 4 weeks (chronic insomnia), consult your health care practitioner.
Source
Official Health Canada record, licence 80002396
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.